Attaya Suvannasankha Selected Research

Bispecific Antibodies

1/2023

Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Attaya Suvannasankha Research Topics

Disease

20	Multiple Myeloma 05/2024 - 09/2006
12	Neoplasms (Cancer) 05/2024 - 10/2006
5	Breast Neoplasms (Breast Cancer) 12/2014 - 06/2002
3	Infections 07/2018 - 05/2003
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2014
2	Disease Progression 11/2021 - 01/2020
2	Plasmacytoma 06/2018 - 08/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2006 - 05/2004
1	Residual Neoplasm 01/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2019
1	Granuloma 12/2018
1	Autoimmune Diseases (Autoimmune Disease) 07/2018
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2018
1	Pain (Aches) 06/2018
1	Erythema 06/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Neutropenia 01/2017
1	Adenocarcinoma 10/2015
1	Hypoxia (Hypoxemia) 12/2014
1	Osteoporosis 01/2014
1	Hematologic Neoplasms (Hematological Malignancy) 01/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2006
1	Thrombocytopenia (Thrombopenia) 09/2006

Drug/Important Bio-Agent (IBA)

6	belantamab mafodotinIBA 04/2024 - 01/2020
4	Immunomodulating AgentsIBA 05/2024 - 01/2020
3	Proteasome InhibitorsIBA 11/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 11/2004 - 06/2002
2	B-Cell Maturation AntigenIBA 01/2023 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2020
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2010 - 10/2006
1	pembrolizumabIBA 04/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2019
1	Amyloidogenic ProteinsIBA 01/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019
1	AutoantibodiesIBA 07/2018
1	AgglutininsIBA 07/2018
1	CD100 antigenIBA 01/2018
1	daratumumabIBA 01/2017
1	pomalidomideIBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Cell Adhesion MoleculesIBA 12/2016
1	Gemcitabine FDA Link 10/2015
1	heparanaseIBA 08/2015
1	infigratinibIBA 08/2015
1	Messenger RNA (mRNA)IBA 12/2014
1	AdrenomedullinIBA 12/2014
1	Peptides (Polypeptides)IBA 12/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 09/2014
1	RNA Precursors (Precursor, mRNA)IBA 09/2014
1	Parathyroid Hormone (Parathormone)IBA 01/2014
1	AntibodiesIBA 01/2014
1	Estrogen ReceptorsIBA 01/2014
1	Everolimus FDA Link 01/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2014
1	ACE-011IBA 01/2014
1	activin AIBA 01/2014
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2014
1	Anabolic AgentsIBA 01/2014
1	strontium ranelate (protelos)IBA 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	LigandsIBA 11/2012
1	Immunoglobulins (Immunoglobulin)IBA 11/2012
1	IPH-2101IBA 11/2012
1	Death-Associated Protein KinasesIBA 01/2012
1	Histone Deacetylase InhibitorsIBA 07/2011
1	ENMD 2076IBA 08/2010
1	Aurora KinasesIBA 08/2010
1	NF-kappa B (NF-kB)IBA 03/2008
1	OSU 03012IBA 08/2007
1	Celecoxib (Celebrex)FDA Link 08/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2007
1	Cytidine Triphosphate (CTP)IBA 01/2007
1	Prednisone (Sone)FDA LinkGeneric 01/2007
1	Thalidomide (Thalomid)FDA Link 01/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2006
1	fms-Like Tyrosine Kinase 3IBA 10/2006
1	JNK Mitogen-Activated Protein KinasesIBA 10/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2006
1	Bortezomib (Velcade)FDA Link 09/2006
1	Methylprednisolone FDA LinkGeneric 09/2006
1	GlucocorticoidsIBA 09/2006
1	Core Binding Factors (Core-Binding Factor)IBA 05/2004
1	major vault proteinIBA 05/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2004
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 05/2004
1	core binding factor alphaIBA 05/2004

Therapy/Procedure

7	Therapeutics 01/2023 - 07/2011
3	Drug Therapy (Chemotherapy) 07/2018 - 10/2015
1	Intravenous Infusions 01/2020
1	Liver Transplantation 12/2018
1	Orchiectomy (Orchidectomy) 06/2018
1	Stem Cell Transplantation 01/2014